Cargando…

Electrophysiological Studies into the Safety of the Anti-diarrheal Drug Clotrimazole during Oral Rehydration Therapy

BACKGROUND AND AIMS: Morbidity and mortality from acute diarrheal disease remains high, particularly in developing countries and in cases of natural or man-made disasters. Previous work has shown that the small molecule clotrimazole inhibits intestinal Cl(-) secretion by blocking both cyclic nucleot...

Descripción completa

Detalles Bibliográficos
Autores principales: Lexmond, Willem S., Rufo, Paul A., Fiebiger, Edda, Lencer, Wayne I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583490/
https://www.ncbi.nlm.nih.gov/pubmed/26405813
http://dx.doi.org/10.1371/journal.pntd.0004098
_version_ 1782391860490141696
author Lexmond, Willem S.
Rufo, Paul A.
Fiebiger, Edda
Lencer, Wayne I.
author_facet Lexmond, Willem S.
Rufo, Paul A.
Fiebiger, Edda
Lencer, Wayne I.
author_sort Lexmond, Willem S.
collection PubMed
description BACKGROUND AND AIMS: Morbidity and mortality from acute diarrheal disease remains high, particularly in developing countries and in cases of natural or man-made disasters. Previous work has shown that the small molecule clotrimazole inhibits intestinal Cl(-) secretion by blocking both cyclic nucleotide- and Ca(2+)-gated K(+) channels, implicating its use in the treatment of diarrhea of diverse etiologies. Clotrimazole, however, might also inhibit transporters that mediate the inwardly directed electrochemical potential for Na(+)-dependent solute absorption, which would undermine its clinical application. Here we test this possibility by examining the effects of clotrimazole on Na(+)-coupled glucose uptake. MATERIALS AND METHODS: Short-circuit currents (Isc) following administration of glucose and secretagogues were studied in clotrimazole-treated jejunal sections of mouse intestine mounted in Ussing chambers. RESULTS: Treatment of small intestinal tissue with clotrimazole inhibited the Cl(-) secretory currents that resulted from challenge with the cAMP-agonist vasoactive intestinal peptide (VIP) or Ca(2+)-agonist carbachol in a dose-dependent fashion. A dose of 30 μM was effective in significantly reducing the Isc response to VIP and carbachol by 50% and 72%, respectively. At this dose, uptake of glucose was only marginally affected (decreased by 14%, p = 0.37). There was no measurable effect on SGLT1-mediated sugar transport, as uptake of SGLT1-restricted 3-O-methyl glucose was equivalent between clotrimazole-treated and untreated tissue (98% vs. 100%, p = 0.90). CONCLUSION: Treatment of intestinal tissue with clotrimazole significantly reduced secretory responses caused by both cAMP- and Ca(2+)-dependent agonists as expected, but did not affect Na(+)-coupled glucose absorption. Clotrimazole could thus be used in conjunction with oral rehydration solution as a low-cost, auxiliary treatment of acute secretory diarrheas.
format Online
Article
Text
id pubmed-4583490
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-45834902015-10-02 Electrophysiological Studies into the Safety of the Anti-diarrheal Drug Clotrimazole during Oral Rehydration Therapy Lexmond, Willem S. Rufo, Paul A. Fiebiger, Edda Lencer, Wayne I. PLoS Negl Trop Dis Research Article BACKGROUND AND AIMS: Morbidity and mortality from acute diarrheal disease remains high, particularly in developing countries and in cases of natural or man-made disasters. Previous work has shown that the small molecule clotrimazole inhibits intestinal Cl(-) secretion by blocking both cyclic nucleotide- and Ca(2+)-gated K(+) channels, implicating its use in the treatment of diarrhea of diverse etiologies. Clotrimazole, however, might also inhibit transporters that mediate the inwardly directed electrochemical potential for Na(+)-dependent solute absorption, which would undermine its clinical application. Here we test this possibility by examining the effects of clotrimazole on Na(+)-coupled glucose uptake. MATERIALS AND METHODS: Short-circuit currents (Isc) following administration of glucose and secretagogues were studied in clotrimazole-treated jejunal sections of mouse intestine mounted in Ussing chambers. RESULTS: Treatment of small intestinal tissue with clotrimazole inhibited the Cl(-) secretory currents that resulted from challenge with the cAMP-agonist vasoactive intestinal peptide (VIP) or Ca(2+)-agonist carbachol in a dose-dependent fashion. A dose of 30 μM was effective in significantly reducing the Isc response to VIP and carbachol by 50% and 72%, respectively. At this dose, uptake of glucose was only marginally affected (decreased by 14%, p = 0.37). There was no measurable effect on SGLT1-mediated sugar transport, as uptake of SGLT1-restricted 3-O-methyl glucose was equivalent between clotrimazole-treated and untreated tissue (98% vs. 100%, p = 0.90). CONCLUSION: Treatment of intestinal tissue with clotrimazole significantly reduced secretory responses caused by both cAMP- and Ca(2+)-dependent agonists as expected, but did not affect Na(+)-coupled glucose absorption. Clotrimazole could thus be used in conjunction with oral rehydration solution as a low-cost, auxiliary treatment of acute secretory diarrheas. Public Library of Science 2015-09-25 /pmc/articles/PMC4583490/ /pubmed/26405813 http://dx.doi.org/10.1371/journal.pntd.0004098 Text en © 2015 Lexmond et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Lexmond, Willem S.
Rufo, Paul A.
Fiebiger, Edda
Lencer, Wayne I.
Electrophysiological Studies into the Safety of the Anti-diarrheal Drug Clotrimazole during Oral Rehydration Therapy
title Electrophysiological Studies into the Safety of the Anti-diarrheal Drug Clotrimazole during Oral Rehydration Therapy
title_full Electrophysiological Studies into the Safety of the Anti-diarrheal Drug Clotrimazole during Oral Rehydration Therapy
title_fullStr Electrophysiological Studies into the Safety of the Anti-diarrheal Drug Clotrimazole during Oral Rehydration Therapy
title_full_unstemmed Electrophysiological Studies into the Safety of the Anti-diarrheal Drug Clotrimazole during Oral Rehydration Therapy
title_short Electrophysiological Studies into the Safety of the Anti-diarrheal Drug Clotrimazole during Oral Rehydration Therapy
title_sort electrophysiological studies into the safety of the anti-diarrheal drug clotrimazole during oral rehydration therapy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583490/
https://www.ncbi.nlm.nih.gov/pubmed/26405813
http://dx.doi.org/10.1371/journal.pntd.0004098
work_keys_str_mv AT lexmondwillems electrophysiologicalstudiesintothesafetyoftheantidiarrhealdrugclotrimazoleduringoralrehydrationtherapy
AT rufopaula electrophysiologicalstudiesintothesafetyoftheantidiarrhealdrugclotrimazoleduringoralrehydrationtherapy
AT fiebigeredda electrophysiologicalstudiesintothesafetyoftheantidiarrhealdrugclotrimazoleduringoralrehydrationtherapy
AT lencerwaynei electrophysiologicalstudiesintothesafetyoftheantidiarrhealdrugclotrimazoleduringoralrehydrationtherapy